UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid

Analytical and bioanalytical chemistry, 2005-01, Vol.381 (1), p.110-118

Maurer, Hans H

2005

Volltextzugriff (PDF)

The NTCP‐inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics

Clinical pharmacology and therapeutics, 2018-02, Vol.103 (2), p.341-348

2018

Volltextzugriff (PDF)

Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine

Therapeutic drug monitoring, 2006-06, Vol.28 (3), p.447-453

2006

Volltextzugriff (PDF)

Metabolism of designer drugs of abuse

Current drug metabolism, 2005-06, Vol.6 (3), p.259-274

2005

Volltextzugriff (PDF)

Environmental risk assessment of medicinal products for human use according to European Commission recommendations

Environmental toxicology, 2004-06, Vol.19 (3), p.226-240

2004

Volltextzugriff (PDF)

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins

New Psychoactive Substances, 2018, Vol.252, p.165-190

2018

Volltextzugriff (PDF)

Neuropharmacology of Synthetic Cathinones

Handbook of experimental pharmacology, 2018, Vol.252, p.113-142

2018

Volltextzugriff (PDF)

Designer Benzodiazepines: Another Class of New Psychoactive Substances

Handbook of experimental pharmacology, 2018, Vol.252, p.383-410

2018

Volltextzugriff (PDF)

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution

New Psychoactive Substances, 2018, Vol.252, p.191-226

2018

Volltextzugriff (PDF)

In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures

Analytical and bioanalytical chemistry, 2019-07, Vol.411 (19), p.4751-4763

2019

Volltextzugriff (PDF)

Bioanalytical Methods for New Psychoactive Substances

New Psychoactive Substances, 2018, Vol.252, p.413-439

2018

Volltextzugriff (PDF)

Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

Analytical and bioanalytical chemistry, 2011-07, Vol.400 (10), p.3481-3489

2011

Volltextzugriff (PDF)

Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances

New Psychoactive Substances, 2018, Vol.252, p.143-164

2018

Volltextzugriff (PDF)

Automated Mass Spectral Deconvolution and Identification System for GC-MS Screening for Drugs, Poisons, and Metabolites in Urine

Clinical chemistry (Baltimore, Md.), 2010-04, Vol.56 (4), p.575-584

2010

Volltextzugriff (PDF)

Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology

Clinical biochemistry, 2005-04, Vol.38 (4), p.310-318

Maurer, Hans H.

2005

Volltextzugriff (PDF)

A multi‐analyte approach to help in assessing the severity of acute poisonings – Development and validation of a fast LC–MS/MS quantification approach for 45 drugs and their relevant metabolites with one‐point calibration

Drug testing and analysis, 2018-01, Vol.10 (1), p.164-176

2018

Volltextzugriff (PDF)

Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse

Pharmacogenomics, 2011-02, Vol.12 (2), p.215-233

2011

Volltextzugriff (PDF)

Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action

New Psychoactive Substances, 2018, Vol.252, p.227-260

2018

Volltextzugriff (PDF)

Wastewater Analysis for Community-Wide Drugs Use Assessment

New Psychoactive Substances, 2018, Vol.252, p.543-566

2018

Volltextzugriff (PDF)

Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control

Clinical chemistry and laboratory medicine, 2004-01, Vol.42 (11), p.1310-1324

Maurer, Hans H.

2004

Volltextzugriff (PDF)

Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP)

Journal of mass spectrometry., 2015-10, Vol.50 (10), p.1163-1174

2015

Volltextzugriff (PDF)

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class

Toxicology letters, 2016-01, Vol.241, p.82-94

2016

Volltextzugriff (PDF)

High prevalence of unknown co-medication in hospitalised patients

European journal of clinical pharmacology, 2004-07, Vol.60 (5), p.363-368

2004

Volltextzugriff (PDF)

New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology

1st ed. 2018., 2019

Volltextzugriff (PDF)

Toxicokinetics of NPS: Update 2017

New Psychoactive Substances, 2018, Vol.252, p.441-459

2018

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieNew Psychoactive Substances

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Englisch
(130)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Life Sciences & Biomedicine
(121)
Humans
(84)
Biological And Medical Sciences
(61)
Chemistry
(61)
Physical Sciences
(58)
Toxicology
(58)
Medical Sciences
(57)
Pharmacology & Pharmacy
(51)
Chemistry, Analytical
(50)
Biochemistry & Molecular Biology
(43)
Animals
(42)
Biochemical Research Methods
(42)
Male
(35)
Rats
(34)
Gas Chromatography-Mass Spectrometry - Methods
(33)
Pharmacology. Drug Treatments
(32)
Metabolism
(30)
Gas Chromatography-Mass Spectrometry
(28)
Analysis
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid

The NTCP‐inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics

Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine

Metabolism of designer drugs of abuse

Environmental risk assessment of medicinal products for human use according to European Commission recommendations

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins

Neuropharmacology of Synthetic Cathinones

Designer Benzodiazepines: Another Class of New Psychoactive Substances

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution

In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures

Bioanalytical Methods for New Psychoactive Substances

Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances

Automated Mass Spectral Deconvolution and Identification System for GC-MS Screening for Drugs, Poisons, and Metabolites in Urine

Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology

A multi‐analyte approach to help in assessing the severity of acute poisonings – Development and validation of a fast LC–MS/MS quantification approach for 45 drugs and their relevant metabolites with one‐point calibration

Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse

Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action

Wastewater Analysis for Community-Wide Drugs Use Assessment

Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control

Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP)

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class

High prevalence of unknown co-medication in hospitalised patients

New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology

Toxicokinetics of NPS: Update 2017

Aktive Filter

Suchergebnisse filtern